Tuberculosis focused through the molecular biology zoom;La tuberculosis vista con el lente de aproximacion de la biologia molecular

Medicina

Volumn 60, Issue 1, 2000, Pages 17-25

  Barrera, Lucia ^a,b  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^b Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

Author keywords

Molecular biology; Tuberculosis

Indexed keywords

ANTIGEN; DNA;

BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; CONFERENCE PAPER; GENOME; MOLECULAR BIOLOGY; MUTAGENESIS; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; RESEARCH; TUBERCULOSIS;

HUMANS; MOLECULAR BIOLOGY; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 0033959216     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Cole ST, Brosch R, Parhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete sequence. Nature 1998; 393: 537-54.
2. Mizrahi V, Andersen SJ. DNA repair in Mycobacterium tuberculosis. What have we learnt from the genome sequence? Mol Microbiol 1998; 29: 1331-9.
3. Moir DT, Shaw KJ, Hare RS, et al. Genomics and antimicrobial drug discovery. Antimicrob Agents Chemother 1999; 43: 439-46.
4. Strauss EJ, Falkow S. Microbial pathogenesis: genomics and beyond. Science 1997; 276: 707-12.
5. Stead WW. The origin and erratic global spread of tuberculosis. How the past explains the present and is the key to the future. Clin Chest Med 1997; 18: 65-77.
6. Schluger NW, Rom WN. The host response to tuberculosis. Am J Respir Cirt Care Med 1998; 157: 679-91.
7. Bellamy R, Ruwende C, Corrah T, et al. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338: 640-44.
8. Van Soolingen D, Hemans PWM. Epidemiology of tuberculosis by DNA fingerprinting. Eur Respir J 1995; 8: 649s-56s.
9. Niemann S, Richter E, Rusch-Gerdes S. Stability of IS6110 restriction fragment length polymorphism patterns of multidrug-resistant Mycobacterium tuberculosis strains. J Clin Microbiol 1999; 37: 3078-9.
10. Fujiwara PI, Sherman LF. Multidrug-resistant tuberculosis: many paths, same truth. Int J Tuberc Lung Dis 1997; 1: 297-8.
11. Aita J, Barrera L, Ritacco V, et al. Hospital transmission of multidrug-resistant Mycobacterium tuberculosis in Rosario, Argentina. Medicina (Buenos Aires) 1996; 56: 48-50.
12. Morcillo N, Alito A, Romano Ml, et al. Multidrug Resistant tuberculosis outbreak in Buenos Aires. DNA fingerprinting analysis of isolates. Medicina (Buenos Aires) 1996; 56: 45-7.
13. Ritacco V, DiLonardo M, Reniero A, et al. Nosocomial spread of HIV-related multidrug resistant tuberculosis in Buenos Aires. JID 1997; 176: 637-42.
14. Bauer J, Thomsen VO, Poulsen S, Andersen AB. False-positive results from cultures of Mycobacterium tuberculosis due to laboratory cross-contamination confirmed by restriction fragment length polymorhism. J Clin Microbiol 1997; 35: 988-91.
15. Van Duin JM, Pijnenburg JEM, van Rijswoud CM, et al. Investigation of cross contamination in a Mycobacterium tuberculosis laboratory using IS6110 DNA fingerprinting. Int J Tuberc Lung Dis 1998, 1: 425-29.
16. Jasmer RM, Ponce de Leon A, Hopewell PC, et al. Tuberculosis in mexican-born persons in San Francisco: reactivation, acquired infection and transmission. Int J Tuberc Lung Dis 1997; 1: 536-41.
17. Chin DPK, DeReimer K, Small PM, et al. Interaction of factors contributing to the incidence of tuberculosis in San Francisco. Am J Respir Dis Crit Care Med 1998; 158: 1797-803.
18. Borgdorff MW, Nagelkerke NJD, van Soolingen D, et al. Analysis of tuberculosis transmission between nationalities in the Netherlands in the period 1993-1995 using DNA fingerprinting. Am J Epidemiol 1998; 147: 187-95.
19. Borgdorff MW, Nagelkerke NJD, van Soolingen D, et al. Transmission of tuberculosis in The Netherlands: an analysis using DNA fingerprinting. Int J Tuberc Lung Dis 1999; 3: 202-6.
20. Van Soolingen D, Qian L, Haas PWE, et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. J Clin Microbiol 1995; 33: 3234-8.
21. Sreevatsan S, Pan X, Stockbauer KE, et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex isolates indicates evolutionary recent global dissemination. Proc Natl Acad Sci USA 1997; 94: 9869-74.
22. Rhee JT, Piatek AS, Small PM, et al. Molecular epidemiologic evaluation of transmissibility and virulence of Mycobacterium tuberculosis. J Clin Microbiol 1999; 37: 1764-70.
23. Hermans PWM, Messadi F, Guebrexabher H, et al. Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia and the Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. JID 1995; 171: 1504-13.
24. Groves MJ. BCG: the past, present and future of a tuberculosis vaccine. J Pharm Pharmacol 1997; 49 (Suppl 1): 7-15.
25. Cohn DL. Use of the Bacille Calmette-Gurerin vaccination for the prevention of tuberculosis: renewed interest in an old vaccine. Am J Med Sci 1997; 313: 372-6.
26. Brosch R, Gordon SV, Billault A, et al. Use of a Mycobacterium tuberculosis H37Rv bacterial artificial chromosome library for genome mapping, sequencing and comparative genomics. Infect Immunol 1998; 66: 221-29.
27. Orme IM. Progress in the development of new vaccines against tuberculosis. Int J Tuberc Lung Dis 1997; 1: 95-100.
28. Huygen K. DNA vaccines: application to tuberculosis. Int J Tuberc Lung Dis 1998; 2: 971-8.
29. Gutiérrez MC, Galán JC, Blázquez J, et al. Molecular markers demonstrate that the first described multidrug-resistant Mycobacterium bovis outbreak was due to Mycobacterium tuberculosis. J Clin Microbiol 1999; 37: 971-5.
30. Frothingham R, Strickland BJ, Bretzel G, et al. Phenotypic and genotypic characterization of Mycobacterium africanum isolates from West Africa. J Clin Microbiol 1999; 37: 1921-6.
31. Rodriguez JG, Fissantoti JC, del Portillo P, et al. Amplification of a 500 base-pair fragment from cultured isolates of Mycobacterium bovis. J Clin Microbiol 1999; 37: 2330-2.
32. American Thoracic Society. Rapid diagnostic tests for tuberculosis. What is the appropriate use? Am J Respir Crit Care Med 1997; 155: 1804-14.
33. Centers for Disease Control and Prevention. Nucleic Acid Amplification Tests for Tuberculosis. MMWR 1996; 45: 950-2.
34. Ieven M, Goossens H. Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory. Clin Microbiol Rev 1997; 10: 242-56.
35. Jacobs WR, Barletta RG, Udani R, et al. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of lucierase reporter phages. Science 1993; 260: 819-22.
36. Carrière C, Riska PF, Zimhony O, et al. Conditionally replicating luciferase reporter phages: improved sensitivity for rapid detection and assesment of drug susceptibility of Mycobacterium tuberculosis. J Clin Microbiol 1997; 35: 3232-9.
37. Wilson SM, Al-Suwiadi Z, McNerney R, et al. Evaluation of a new rap d bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nature Medicine 1997; 4: 465-8.
38. Watterson SA, Wilson SM, Yates MD, et al. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 1998; 36: 1969-73.
39. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuoerculosis: 1998 update. Tubercle Lung Dis 1998; 79: 3-29.
40. Williams DL, Spring L, Collins L, et al. Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob Agents Cnemother 1998; 42: 1853-7.
41. Chopra I, Brennan P. Molecular action of antimycobaterial agents. Tubercle Lung Dis 1998; 78: 89-98.
42. Schraufnage DE. Tuberculosis treatment for the beginning of the next century. Int J Tuberc Lung Dis 1999; 3: 651-62.
43. Barrow ELW, Winchester GA, Staas JK, et al. Use of microsphere technology for targeted delivery of rifampm to Mycobacterium tuberculosis-infected macrophages. Antimicrob Agents Chemother 1998; 42: 2682-9.
44. Hancock REW, Knowles D. Are we approaching the end of the antibiotic era? Curr Opin Microbiol 1998; 1 : 493-4.
45. Rom WN, Yie T, Tchu-wong K. Development of a suicide gene as a novel approach to killing Mycobacterium tuberculosis. Am J Respir Crit Care Med 1997; 156: 1993-8.